CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 173 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $397,000 | -62.7% | 16,000 | -31.6% | 0.00% | -100.0% |
| Q2 2018 | $1,064,000 | +17.4% | 23,406 | +112.8% | 0.00% | 0.0% |
| Q3 2017 | $906,000 | -93.9% | 11,000 | -93.2% | 0.00% | -94.7% |
| Q3 2015 | $14,802,000 | +1817.4% | 160,959 | +1731.4% | 0.02% | +1800.0% |
| Q2 2015 | $772,000 | +164.4% | 8,789 | +83.1% | 0.00% | – |
| Q3 2013 | $292,000 | +39.7% | 4,800 | +54.2% | 0.00% | – |
| Q2 2013 | $209,000 | – | 3,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |